Tag Archives: Umbilical cord

India: bank heavily on stem cells

Stem Cell Therapy

Stem cell banking is gaining popularity in Indore and Bhopal as increasing numbers of parents are taking to the concept, which has the potential to secure their child’s healthy life.

The number of people who have registered for stem cell banking has increased multifold in Indore and Bhopal, placing them among the top 10 cities in the country, according to industry estimates.

Every month about 500 parents from Indore and Bhopal are investing in the potential life-saving power of stem cells by preserving the umbilical cord at child birth, whose stem cells help fight against any future life
Read More…

Artificial skin created using stem cells

In a first, scientists have grown artificial skin using stem cells derived from the umbilical cord.

Scientists from the Tissue Engineering Research Group at the Department of Histology at the University of Granada demonstrated the ability of Wharton jelly mesenschymal stem cells to turn to oral-mucosa or skin-regeneration epithelia.

GREAT BRITAIN – Professor Moves to France due to Lack of Funds for Adult Stem Cell Research

Image via Wikipedia

Colin McGuckin, professor of regenerative medicine at the University of Newcastle and adult stem cell expert has said that government funding goes mostly to embryonic stem cells despite the fact that his work gives immediate practical results.

He has also complained that the university is not able to provide him with adequate structures to carry out his research, adding, “There aren’t many people in the city that know that there is research on adult stem cells.”

The professor, who is a Catholic, is a pioneer in umbilical cord stem cells research, with a study that creates tissue for
Read More…

ITALY – Tumor Institute: safer stem cell transplants

Fondazione IRCCS Istituto Nazionale Tumori di Milano

Methods to provide safer stem cell transplants to individuals who are not completely compatible with the donor are being developed. Encouraging results have come from a post-transplant cellular therapy, which strengthens the immune system against viral infections and tumors, developed for the first time at the National Tumor Institute (INT) in Milan. The INT conducted the first phase I-II study in the world, published in ‘Blood’, whose main objective was to assess the use of a low dose radiochemotherapy, followed by low dose post-transplant infusions CD8-depleted donor lymphocytes after
Read More…

GREAT BRITAIN – StemWay Biotech criticizes Italian government on umbilical cord stem cells

The Health Minister recently held a press conference to launch a program to strengthen the public biobank network, considering that currently on 20% of donations are completed successfully. An informative pamphlet was also distributed about “The appropriate use of umbilical cord stem cells“.

The StemWay Biotech company, through its Vice-President Dr. Paolo Rubini, in complete agreement with other biobanks in Italy, with great surprise and dismay, stressed that unfortunately, the measure seems to be more against the autologous conservation of stem cells rather than in favor of donation. As for the scientific statements contained in the informative pamphlet
Read More…